rs111033565

Variant summary

Our verdict is Pathogenic. The variant received 20 ACMG points: 20P and 0B. PS1PS3PM1PM5PP5_Very_Strong

The NM_002769.5(PRSS1):​c.365G>A​(p.Arg122His) variant causes a missense change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000053050: Experimental evidence evaluating an impact on protein function demonstrated the variant to increase autolytic stability of trypsin and enhance autocatalytic trypsin generation (Sahin-Toth_2000), resulting in a gain of function effect." and additional evidence is available in ClinVar. Another nucleotide change resulting in the same amino acid substitution has been previously reported as Pathogenic in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R122G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000055 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000015 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

PRSS1
NM_002769.5 missense

Scores

5
13

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:23O:1

Conservation

PhyloP100: 0.140

Publications

233 publications found
Variant links:
Genes affected
PRSS1 (HGNC:9475): (serine protease 1) This gene encodes a trypsinogen, which is a member of the trypsin family of serine proteases. This enzyme is secreted by the pancreas and cleaved to its active form in the small intestine. It is active on peptide linkages involving the carboxyl group of lysine or arginine. Mutations in this gene are associated with hereditary pancreatitis. This gene and several other trypsinogen genes are localized to the T cell receptor beta locus on chromosome 7. [provided by RefSeq, Jul 2008]
PRSS1 Gene-Disease associations (from GenCC):
  • hereditary chronic pancreatitis
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Illumina, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_002769.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 20 ACMG points.

PS1
Transcript NM_002769.5 (PRSS1) is affected with MISSENSE_VARIANT having same AA change as one Pathogenic present in ClinVar.
PS3
PS3 evidence extracted from ClinVar submissions: SCV000053050: Experimental evidence evaluating an impact on protein function demonstrated the variant to increase autolytic stability of trypsin and enhance autocatalytic trypsin generation (Sahin-Toth_2000), resulting in a gain of function effect.; SCV000552151: Experimental studies have shown that this missense change affects PRSS1 function (PMID: 11097832, 11748242).; SCV000604930: This variant increases the auto-activation and stability of trypsin, even in the presence of inhibitory factors such as chymotrypsin C (Sahin-Toth 2000, Szabo 2012, Whitcomb 1996), and leads to chronic pancreatic inflammation and acinar cell necrosis in a mouse model (Archer 2006). PMID: 17087933. PMID: 24458023. PMID: 11097832. PMID: 22539344. PMID: 8841182.; SCV001182352: An in vitro study demonstrated that this mutation results in a markedly higher active trypsin level compared to wild type and is resistant to degradation (Szabó, 2012).; SCV004013551: Functional studies provide strong evidence of the variant having a damaging effect on the gene or gene product (PMID: 11097832, 11748242, 31419436).; SCV004047387: Experimental studies have shown that this missense change leads to an increase in both PRSS1 stability and trypsinogen activity, due to an inhibition of autolysis (Kukor et. al., 2002; Sahin-Tóth et. al., 2000).; SCV000568661: Functional studies demonstrated that the R122H variant significantly enhanced autoactivation of cationic trypsinogen in vitro and inhibited autocatalytic inactivation of trypsin (Sahin-Toth et al., 2000).
PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 36 uncertain in NM_002769.5
PM5
Other missense variant is known to change same aminoacid residue: Variant chr7-142751937-C-T is described in ClinVar as Pathogenic. ClinVar VariationId is 11883.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP5
Variant 7-142751938-G-A is Pathogenic according to our data. Variant chr7-142751938-G-A is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 11876.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002769.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRSS1
NM_002769.5
MANE Select
c.365G>Ap.Arg122His
missense
Exon 3 of 5NP_002760.1P07477
PRSS1
NR_172947.1
n.307G>A
non_coding_transcript_exon
Exon 3 of 5
PRSS1
NR_172948.1
n.304G>A
non_coding_transcript_exon
Exon 3 of 5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRSS1
ENST00000311737.12
TSL:1 MANE Select
c.365G>Ap.Arg122His
missense
Exon 3 of 5ENSP00000308720.7P07477
PRSS1
ENST00000486171.5
TSL:5
c.407G>Ap.Arg136His
missense
Exon 4 of 6ENSP00000417854.1E7EQ64
PRSS1
ENST00000492062.2
TSL:2
c.365G>Ap.Arg122His
missense
Exon 3 of 5ENSP00000419912.2H0Y8D1

Frequencies

GnomAD3 genomes
AF:
0.0000551
AC:
8
AN:
145178
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000157
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000302
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000119
AC:
3
AN:
251304
AF XY:
0.00000736
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000264
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000147
AC:
21
AN:
1428358
Hom.:
0
Cov.:
62
AF XY:
0.0000140
AC XY:
10
AN XY:
711842
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0000311
AC:
1
AN:
32204
American (AMR)
AF:
0.00
AC:
0
AN:
42932
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25556
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39646
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85458
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53036
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5710
European-Non Finnish (NFE)
AF:
0.0000166
AC:
18
AN:
1084514
Other (OTH)
AF:
0.0000337
AC:
2
AN:
59302
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.0000147888), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.368
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000551
AC:
8
AN:
145292
Hom.:
0
Cov.:
31
AF XY:
0.0000423
AC XY:
3
AN XY:
70924
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000156
AC:
6
AN:
38344
American (AMR)
AF:
0.00
AC:
0
AN:
14524
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3376
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5110
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4692
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9962
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
280
European-Non Finnish (NFE)
AF:
0.0000302
AC:
2
AN:
66128
Other (OTH)
AF:
0.00
AC:
0
AN:
1986
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.238
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00000850
Hom.:
0

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
13
-
-
Hereditary pancreatitis (14)
9
-
-
not provided (9)
1
-
-
PRSS1-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Uncertain
0.14
D
BayesDel_noAF
Uncertain
-0.030
CADD
Benign
1.5
DANN
Benign
0.65
DEOGEN2
Benign
0.30
T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.022
N
M_CAP
Benign
0.064
D
MetaRNN
Uncertain
0.71
D
MetaSVM
Benign
-0.67
T
MutationAssessor
Benign
0.10
N
PhyloP100
0.14
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-0.16
N
REVEL
Uncertain
0.51
Sift
Benign
0.39
T
Sift4G
Benign
0.40
T
Varity_R
0.21
gMVP
0.57
Mutation Taster
=57/43
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs111033565;
hg19: chr7-142459789;
COSMIC: COSV104604888;
COSMIC: COSV104604888;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.